Clinical trial
The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial
NCT05101798 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- September 14, 2021
- Completion date
- December 25, 2022
- Enrollment
- 7 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
neoplasm, skull base neoplasm